Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...